A Morphological and Behavioral Study of Demyelination and Remyelination in the Cuprizone Model: Insights into APLNR

Boycho Landzhov1, Lyubomir Gaydarski1, Stancho Stanchev1

  • 1Department of Anatomy, Histology and Embryology, Medical University of Sofia, 1431 Sofia, Bulgaria.

Insights

The apelin receptor (APLNR) on NG2-positive cells is crucial for remyelination in a mouse model of multiple sclerosis (MS). APLNR expression changes correlate with myelin repair and behavioral recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Multiple sclerosis (MS) is a chronic neurodegenerative disease characterized by demyelination.
  • The cuprizone model is widely used to study MS pathology, inducing oligodendrocyte damage and demyelination.
  • The subventricular zone (SVZ) is a neurogenic niche, and NG2 marks oligodendrocyte precursor cells vital for myelin repair.

Purpose of the Study:

  • To investigate the role of the apelin receptor (APLNR) in NG2-positive cells during demyelination and remyelination in the cuprizone mouse model.
  • To assess the correlation between APLNR expression, NG2-positive cell dynamics, corpus callosum (CC) integrity, and behavioral outcomes.

Main Methods:

  • Utilized the cuprizone-induced demyelination/remyelination mouse model.
  • Conducted histological and immunofluorescence analyses to evaluate CC morphology and APLNR/NG2 expression in the SVZ.
  • Performed behavioral assessments to measure motor coordination and memory.

Main Results:

  • Cuprizone exposure led to significant CC thinning and area reduction, with partial recovery post-treatment.
  • APLNR-expressing cells increased during demyelination, while NG2-positive cells decreased; the opposite occurred during remyelination.
  • Co-localization of NG2 and APLNR was confirmed, and cell counts correlated with CC changes and behavioral recovery.

Conclusions:

  • NG2-positive cells expressing APLNR are dynamically regulated during demyelination and remyelination.
  • APLNR signaling in NG2-positive cells appears to play a significant role in the remyelination process in MS.
  • These findings suggest APLNR as a potential therapeutic target for promoting myelin repair in MS.

Related Concept Videos